31.23
price down icon1.28%   -0.415
 
loading
前日終値:
$31.65
開ける:
$31.74
24時間の取引高:
1.56M
Relative Volume:
0.38
時価総額:
$14.62B
収益:
$2.27B
当期純損益:
$1.15B
株価収益率:
12.25
EPS:
2.55
ネットキャッシュフロー:
$2.80B
1週間 パフォーマンス:
-7.28%
1か月 パフォーマンス:
-7.12%
6か月 パフォーマンス:
+10.76%
1年 パフォーマンス:
+2.88%
1日の値動き範囲:
Value
$31.00
$31.80
1週間の範囲:
Value
$31.00
$34.14
52週間の値動き範囲:
Value
$24.05
$34.20

Royalty Pharma Plc Stock (RPRX) Company Profile

Name
名前
Royalty Pharma Plc
Name
セクター
Healthcare (1167)
Name
電話
(212) 883-0200
Name
住所
110 EAST 59TH STREET, NEW YORK, NY
Name
職員
0
Name
Twitter
Name
次回の収益日
2025-02-11
Name
最新のSEC提出書
Name
RPRX's Discussions on Twitter

RPRX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RPRX
Royalty Pharma Plc
31.23 14.62B 2.27B 1.15B 2.80B 2.55
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
496.80 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
641.03 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
593.50 36.26B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
269.11 34.91B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
266.96 28.24B 3.81B -644.79M -669.77M -6.24

Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-06-03 ダウングレード UBS Buy → Neutral
2022-06-14 再開されました UBS Buy
2022-05-13 開始されました Scotiabank Sector Outperform
2022-04-27 開始されました Goldman Buy
2022-04-14 アップグレード JP Morgan Neutral → Overweight
2022-04-06 再開されました Morgan Stanley Overweight
2021-10-29 アップグレード Citigroup Neutral → Buy
2021-07-30 開始されました Tigress Financial Buy
2020-11-09 アップグレード UBS Neutral → Buy
2020-07-14 開始されました Evercore ISI In-line
2020-07-13 開始されました BofA Securities Buy
2020-07-13 開始されました Citigroup Neutral
2020-07-13 開始されました Cowen Outperform
2020-07-13 開始されました Goldman Neutral
2020-07-13 開始されました JP Morgan Neutral
2020-07-13 開始されました Morgan Stanley Equal-Weight
2020-07-13 開始されました SunTrust Buy
2020-07-13 開始されました UBS Neutral
すべてを表示

Royalty Pharma Plc (RPRX) 最新ニュース

pulisher
Mar 27, 2025

Virtu Financial LLC Makes New $467,000 Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 27, 2025
pulisher
Mar 27, 2025

Royalty Pharma (NASDAQ:RPRX) Sees Strong Trading VolumeShould You Buy? - MarketBeat

Mar 27, 2025
pulisher
Mar 27, 2025

UBS maintains neutral Royalty Pharma stock with $33 target By Investing.com - Investing.com UK

Mar 27, 2025
pulisher
Mar 27, 2025

UBS Reiterates Neutral Rating on Royalty Pharma (RPRX) - StreetInsider.com

Mar 27, 2025
pulisher
Mar 27, 2025

Citi maintains Buy on Royalty Pharma stock with $40 target By Investing.com - Investing.com UK

Mar 27, 2025
pulisher
Mar 27, 2025

Royalty Pharma Announces Upcoming Investor Day - The Manila Times

Mar 27, 2025
pulisher
Mar 27, 2025

Citi Reiterates Buy Rating on Royalty Pharma (RPRX) - StreetInsider.com

Mar 27, 2025
pulisher
Mar 27, 2025

Royalty Pharma's Investor Day: Strategic Roadmap for Biopharma Innovation Funding - StockTitan

Mar 27, 2025
pulisher
Mar 27, 2025

Mitsubishi UFJ Trust & Banking Corp Has $47.68 Million Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 27, 2025
pulisher
Mar 27, 2025

KLP Kapitalforvaltning AS Acquires New Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 27, 2025
pulisher
Mar 27, 2025

Corient Private Wealth LLC Raises Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 27, 2025
pulisher
Mar 27, 2025

Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Royal London Asset Management Ltd. - MarketBeat

Mar 27, 2025
pulisher
Mar 27, 2025

Thrivent Financial for Lutherans Increases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 27, 2025
pulisher
Mar 26, 2025

Proficio Capital Partners LLC Invests $786,000 in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 26, 2025
pulisher
Mar 26, 2025

Fox Run Management L.L.C. Purchases 16,084 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 26, 2025
pulisher
Mar 26, 2025

Teacher Retirement System of Texas Raises Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 26, 2025
pulisher
Mar 25, 2025

Sciencast Management LP Invests $998,000 in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 25, 2025
pulisher
Mar 25, 2025

Is Royalty Pharma plc (RPRX) The Best Defensive Stock Amid Market Volatility? - Yahoo Finance

Mar 25, 2025
pulisher
Mar 24, 2025

15 Best Defensive Stocks Amid Market Volatility - Insider Monkey

Mar 24, 2025
pulisher
Mar 24, 2025

Koss Olinger Consulting LLC Makes New $269,000 Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 24, 2025
pulisher
Mar 23, 2025

Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by HighTower Advisors LLC - MarketBeat

Mar 23, 2025
pulisher
Mar 23, 2025

(RPRX) Technical Data - Stock Traders Daily

Mar 23, 2025
pulisher
Mar 22, 2025

Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Twin Tree Management LP - MarketBeat

Mar 22, 2025
pulisher
Mar 22, 2025

Horizon Kinetics Asset Management LLC Purchases 90,380 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 22, 2025
pulisher
Mar 21, 2025

Swiss National Bank Lowers Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

Public market insider buying at Canaccord Genuity Group (CF) - The Globe and Mail

Mar 21, 2025
pulisher
Mar 21, 2025

Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks - Barchart

Mar 21, 2025
pulisher
Mar 20, 2025

Raymond James Financial Inc. Purchases New Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 20, 2025
pulisher
Mar 19, 2025

How Do Investors Really Feel About Royalty Pharma? - Benzinga

Mar 19, 2025
pulisher
Mar 19, 2025

Royalty Pharma plc's (NASDAQ:RPRX) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - Simply Wall St

Mar 19, 2025
pulisher
Mar 19, 2025

Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Tredje AP fonden - MarketBeat

Mar 19, 2025
pulisher
Mar 18, 2025

Atria Investments Inc Sells 20,550 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 18, 2025
pulisher
Mar 18, 2025

Jupiter Asset Management Ltd. Invests $4.95 Million in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 18, 2025
pulisher
Mar 17, 2025

AGF Management Ltd. Buys Shares of 98,512 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 17, 2025
pulisher
Mar 16, 2025

Wealthfront Advisers LLC Buys 178,173 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 16, 2025
pulisher
Mar 15, 2025

Amundi Trims Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 15, 2025
pulisher
Mar 15, 2025

River Road Asset Management LLC Trims Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 15, 2025
pulisher
Mar 15, 2025

Zurcher Kantonalbank Zurich Cantonalbank Has $4.48 Million Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 15, 2025
pulisher
Mar 14, 2025

Charles Schwab Investment Management Inc. Boosts Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 14, 2025
pulisher
Mar 12, 2025

Machina Capital S.A.S. Sells 12,740 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 12, 2025
pulisher
Mar 12, 2025

Proficio Capital Partners LLC Makes New $786,000 Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Mar 12, 2025

Royalty Pharma Plc (RPRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$306.36
price down icon 0.55%
$77.05
price down icon 0.71%
$20.64
price up icon 3.37%
$95.34
price down icon 0.02%
biotechnology ONC
$268.90
price up icon 7.38%
大文字化:     |  ボリューム (24 時間):